460 related articles for article (PubMed ID: 34639352)
1. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and acceptability of telehealth and contactless delivery of human papillomavirus (HPV) self-testing for cervical screening with Māori and Pacific women in a COVID-19 outbreak in Aotearoa New Zealand.
Bartholomew K; Grant J; Maxwell A; Bromhead C; Gillett F; Saraf R; Moodabe K; Sherman SM; McPherson G; Flower D; Kathuria J; Crengle S; Massey R; Scott N; Coote P
N Z Med J; 2022 Nov; 135(1565):83-94. PubMed ID: 36356272
[TBL] [Abstract][Full Text] [Related]
4. He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Māori women talk about HPV self-testing cervical screening clinical pathways.
Adcock A; Stevenson K; Cram F; MacDonald EJ; Geller S; Hermens J; Lawton B
Int J Gynaecol Obstet; 2021 Nov; 155(2):275-281. PubMed ID: 34382217
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus self-testing among unscreened and under-screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical-trial nonresponders.
Sherman SM; Brewer N; Bartholomew K; Bromhead C; Crengle S; Cunningham C; Douwes J; Foliaki S; Grant J; Maxwell A; McPherson G; Scott N; Wihongi H; Potter JD
Health Expect; 2022 Dec; 25(6):2914-2923. PubMed ID: 36161964
[TBL] [Abstract][Full Text] [Related]
7. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous population.
Adcock A; Cram F; Lawton B; Geller S; Hibma M; Sykes P; MacDonald EJ; Dallas-Katoa W; Rendle B; Cornell T; Mataki T; Rangiwhetu T; Gifkins N; Hart S
Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):301-307. PubMed ID: 30614524
[TBL] [Abstract][Full Text] [Related]
9. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
MacDonald EJ; Geller S; Sibanda N; Stevenson K; Denmead L; Adcock A; Cram F; Hibma M; Sykes P; Lawton B
Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):135-141. PubMed ID: 33350455
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
12. A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
Lawton B; MacDonald EJ; Storey F; Stanton JA; Adcock A; Gibson M; Parag V; Sparkes NK; Kaimoana B; King F; Terry M; Watson H; Bennett M; Lambert CS; Geller S; Paasi I; Hibma M; Sykes P; Hawkes D; Saville M
JMIR Res Protoc; 2023 Sep; 12():e51643. PubMed ID: 37707939
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
[TBL] [Abstract][Full Text] [Related]
14. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
[TBL] [Abstract][Full Text] [Related]
15. Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study.
Brewer N; Foliaki S; Gray M; Potter JD; Douwes J
Lancet Reg Health West Pac; 2022 Nov; 28():100551. PubMed ID: 35991536
[TBL] [Abstract][Full Text] [Related]
16. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
Devotta K; Vahabi M; Prakash V; Lofters A
BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
19. The effect of Māori ethnicity misclassification on cervical screening coverage.
Sandiford P; Salvetto M; Bramley D; Wong S; Johnson L
N Z Med J; 2013 Apr; 126(1372):55-65. PubMed ID: 23793178
[TBL] [Abstract][Full Text] [Related]
20. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]